Asian Journal Of Social Pharmacy

Asian Journal of Social Pharmacy

20 June 2015, Volume 10 Issue 2 Previous Issue    Next Issue

论文

The Cost-Benefit Analysis of Government Supervisionof Post-Market Drug Risks

ZHANG Hao;WU Zhi-ang

2015, 10 (2): 57–60; doi:

Abstract ( 412 ) PDF (0KB) ( 221 )

FDA Warning Letter System and Its Enlightenment to China

ZHAO Pin;YANG Yue

2015, 10 (2): 61–65; doi:

Abstract ( 450 ) PDF (0KB) ( 386 )

Analysis on Foreign Corrupt Practices Act and Governance of CommercialBribery Committed by Multinational Enterprises

ZHAO Shu;;TIAN Li-juan

2015, 10 (2): 66–72; doi:

Abstract ( 383 ) PDF (0KB) ( 195 )

Analysis of the Controllability of Drug Risk Based on AHP

YAN Quan;SHAO Rong

2015, 10 (2): 73–78; doi:

Abstract ( 458 ) PDF (0KB) ( 198 )

Foreign Biological Reagent Enterprises in China:Marketing Concepts and Practices

BAI Jian;DAI Juan;LI Ye

2015, 10 (2): 79–81; doi:

Abstract ( 414 ) PDF (0KB) ( 404 )

An Analysis of Doctors’ Incentive Mechanismin Grass-root Medical Organizations

SUN Shu-jun;WU Zhi-ang

2015, 10 (2): 82–85; doi:

Abstract ( 422 ) PDF (0KB) ( 224 )

Problem Analysis of Medical Insurance Fund Management in China

WANG Dong-mei;SUN Li-hua

2015, 10 (2): 86–90; doi:

Abstract ( 331 ) PDF (0KB) ( 196 )

Research on the Essential Principles of Safetyand Performance of Medical Devices

LI Fei;;BI Kai-shun;YUAN Peng

2015, 10 (2): 91–96; doi:

Abstract ( 400 ) PDF (0KB) ( 329 )

Study on O2O Pharmacy E-commerce Based on SWOT Analysis

HAN Xue-ting;HUANG Zhe

2015, 10 (2): 97–101; doi:

Abstract ( 768 ) PDF (0KB) ( 235 )

Research Report on Social Requirements for Pharmacy Graduates

LUO Yu-jing;WU Chun-fu

2015, 10 (2): 102–106; doi:

Abstract ( 307 ) PDF (0KB) ( 213 )